Eckelman Brendan P. has filed 4 insider transactions across 1 company since May 2024.
Most recent transaction: a grant/award of 433888 shares of Inhibrx Biosciences, Inc. ($INBX) on May 29, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2024 | Inhibrx Biosciences, Inc. | $INBX | Eckelman Brendan P. | Chief Scientific Officer | A | Common Stock | 433888 | $0.00 | 473,888.0000 | 49,234,000 | 1084.72% | 0.88% |
| May 29, 2024 | Inhibrx Biosciences, Inc. | $INBX | Eckelman Brendan P. | Chief Scientific Officer | A | Common Stock | 40000 | $0.00 | 473,888.0000 | 49,234,000 | 9.22% | 0.08% |
| May 29, 2024 | Inhibrx Biosciences, Inc. | $INBX | Eckelman Brendan P. | Chief Scientific Officer | A | Common Stock | 40000 | $0.00 | 473,888.0000 | 49,234,000 | 9.22% | 0.08% |
| May 30, 2024 | Inhibrx Biosciences, Inc. | $INBX | Eckelman Brendan P. | Chief Scientific Officer | A | Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 14,475,904 | 9999.99% | 1.21% |